FIA
ANEB

FNY Investment Advisers’s Anebulo Pharmaceuticals ANEB Stock Holding History

FNY Investment Advisers’s Portfolio ANEB Stock Details ANEB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed – – 760
2025
Q4 		$0 Buy
100
+5
+5% +$11 ﹤0.01% 922
2025
Q3 		$0 Buy
+95
New +$224 ﹤0.01% 1224

FNY Investment Advisers's ANEB Position: Q1 2026 in Review

FNY Investment Advisers sold out of Anebulo Pharmaceuticals (ANEB) in Q1 2026, closing a stake of 100 shares.

FNY Investment Advisers first reported a position in ANEB in Q3 2025 and held it in 2 quarters. The position peaked at $0 in Q4 2025. 0 funds tracked by Wall St. Rank hold ANEB as of Q1 2026.

  • FNY Investment Advisers reported no remaining Anebulo Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 100 Anebulo Pharmaceuticals shares in Q1 2026.
  • FNY Investment Advisers first reported a position in Anebulo Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • FNY Investment Advisers's Anebulo Pharmaceuticals position peaked at $0 in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.